Oncology Clinical Trials – Tips for Study Start-Up

Oncology Clinical trials in all their complexity can pose unique challenges. A dynamic interactive response technology (IRT) system is crucial to respond quickly to aspects like frequent dosing modifications, variable cycle quantities, cohort and expiry management, and other unpredictable factors.

In this recording, we team up with Abby Stephen’s of Suvoda, an industry-leading IRT supplier focusing on complex patient randomization and clinical supply chain challenges.
We discuss

  • The increasing complexity of oncology trials in every phase
  • Recommendations for when to include IRT and packaging in protocol development
  • Expected vs. unexpected mid-study changes and how to best handle them
  • Supply strategies (visit schedule expansion, dose and dispensation schedules, predictive resupply, etc.)
  • Chemotherapy and comparator sourcing
  • Working with vendors and partners to maximize visibility, flexibility, and control to improve patient centricity

Tips for Study Start-Up in Oncology Clinical Trials. (mp3)

Our dedicated team of specialists will be happy to discuss any of your Clinical Trials Regulation questions or concerns. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email talkfuture@pci.com